TAYLOR CROSSLEY: Open Payments
NPI 1679125363 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 35 payments from 14 companies in 2025. Trend: 2023 $483 · 2024 $365 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $156 |
| Corium, LLC | 7 | $127 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| ABBVIE INC. | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $19 |
Products named: Azstarys, Auvelity, REXULTI, ABILIFY MAINTENA, VRAYLAR, FANAPT, Jornay PM, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
